BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Tuesday, March 31, 2015 at 8:30 am Eastern Time to discuss its fiscal year 2014 financial results before the market opens.

Conference Call Details

The conference call may be accessed by dialing (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 from international locations. The conference call will also be available via the internet at www.bg-medicine.com.

Listeners are encouraged to login at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at www.bg-medicine.com. Please connect to the website at least 15 minutes prior to the call to download and install any necessary audio software.

About BG Medicine

BG Medicine Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com.

The BG Medicine Inc. logo is available for download here.

CONTACT: Steve Hall
         
         EVP & Chief Financial Officer
         
         (781) 890-1199
BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more BG Medicine (CE) Charts.
BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more BG Medicine (CE) Charts.